Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 456

1.

The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tobacco Use and Nitrosamine-based Carcinogenesis Risk among Active Smokers.

Wang Y, Chanickal Narayanapillai S, Tessier KM, Strayer LG, Upadhyaya P, Hu Q, Kingston R, Salloum RG, Lu J, Hecht SS, Hatsukami DK, Fujioka N, Xing C.

Cancer Prev Res (Phila). 2020 Feb 26. pii: canprevres.0501.2019. doi: 10.1158/1940-6207.CAPR-19-0501. [Epub ahead of print]

PMID:
32102948
2.

The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial.

Smith TT, Koopmeiners JS, White CM, Denlinger-Apte RL, Pacek LR, De Jesús VR, Wang L, Watson C, Blount BC, Hatsukami DK, Benowitz NL, Donny EC, Carpenter MJ.

Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):880-886. doi: 10.1158/1055-9965.EPI-19-0963. Epub 2020 Feb 26.

PMID:
32102910
3.

Mouth-Level Nicotine Intake Estimates from Discarded Filter Butts to Examine Compensatory Smoking in Low Nicotine Cigarettes.

Smith TT, Koopmeiners JS, Hatsukami DK, Tessier KM, Benowitz NL, Murphy SE, Strasser AA, Tidey JW, Blount BC, Valentin L, Bravo Cardenas R, Watson C, Pirkle JL, Donny EC.

Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):643-649. doi: 10.1158/1055-9965.EPI-19-0905. Epub 2020 Feb 26.

PMID:
32102909
4.

Cancer-Related Distress: Revisiting the Utility of the National Comprehensive Cancer Network Distress Thermometer Problem List in Women With Gynecologic Cancers.

Jewett PI, Teoh D, Petzel S, Lee H, Messelt A, Kendall J, Hatsukami D, Everson-Rose SA, Blaes AH, Vogel RI.

JCO Oncol Pract. 2020 Feb 24:JOP1900471. doi: 10.1200/JOP.19.00471. [Epub ahead of print]

PMID:
32091952
5.

Applying tobacco, environmental and dietary-related biomarkers to understand cancer etiology and evaluate prevention strategies.

Peterson LA, Balbo S, Fujioka N, Hatsukami DK, Hecht SS, Murphy SE, Stepanov I, Tretyakova N, Turesky RJ, Villalta PW.

Cancer Epidemiol Biomarkers Prev. 2020 Feb 12. pii: cebp.1356.2019. doi: 10.1158/1055-9965.EPI-19-1356. [Epub ahead of print]

PMID:
32051197
6.

Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers.

Carroll DM, Murphy SE, Benowitz NL, Strasser AA, Kotlyar M, Hecht SS, Carmella SG, McClernon FJ, Pacek LR, Dermody SS, Vandrey RG, Donny EC, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):871-879. doi: 10.1158/1055-9965.EPI-19-0644. Epub 2020 Feb 12.

PMID:
32051195
7.

High School Youth and E-cigarettes: The Influence of Modified Risk Statements and Flavors on E-cigarette Packaging.

Katz SJ, Shi W, Erkkinen M, Lindgren B, Hatsukami D.

Am J Health Behav. 2020 Mar 1;44(2):130-145. doi: 10.5993/AJHB.44.2.2.

PMID:
32019647
8.

Can the Public Be Educated About Constituents in Smokeless Tobacco? A Three-Wave Randomized Controlled Trial.

Loken B, Borgida E, Wang T, Madzelan MK, Williams AL, Hatsukami D, Stepanov I.

Nicotine Tob Res. 2020 Feb 3. pii: ntz241. doi: 10.1093/ntr/ntz241. [Epub ahead of print]

PMID:
32010948
9.

Biomarkers of Exposure among Adult Smokeless Tobacco Users in the Population Assessment of Tobacco and Health Study (Wave 1, 2013-2014).

Cheng YC, Reyes-Guzman CM, Christensen CH, Rostron BL, Edwards KC, Wang L, Feng J, Jarrett JM, Ward CD, Xia B, Kimmel HL, Conway K, Leggett C, Taylor K, Lawrence C, Niaura R, Travers MJ, Hyland A, Hecht SS, Hatsukami DK, Goniewicz ML, Borek N, Blount BC, van Bemmel DM.

Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):659-667. doi: 10.1158/1055-9965.EPI-19-0766. Epub 2020 Jan 27.

PMID:
31988072
10.

Dynamic borrowing in the presence of treatment effect heterogeneity.

Kotalik A, Vock DM, Donny EC, Hatsukami DK, Koopmeiners JS.

Biostatistics. 2020 Jan 24. pii: kxz066. doi: 10.1093/biostatistics/kxz066. [Epub ahead of print]

PMID:
31977040
11.

Nicotine Standards in the United States.

Stanton CA, Hatsukami DK.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S1-S4. doi: 10.1093/ntr/ntz191.

12.

The Role of Compensation in Nicotine Reduction.

Benowitz NL, Donny EC, Edwards KC, Hatsukami D, Smith TT.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S16-S18. doi: 10.1093/ntr/ntz120.

13.

The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings.

Smith TT, Donny EC, Luo X, Allen AM, Carroll DM, Denlinger-Apte RL, Dermody SS, Koopmeiners JS, McClernon FJ, Pacek LR, Vandrey R, Hatsukami DK.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S73-S80. doi: 10.1093/ntr/ntz158.

14.

Effects of 6-Week Use of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness.

Tidey JW, Colby SM, Denlinger-Apte RL, Goodwin C, Cioe PA, Cassidy RN, Swift RM, Lindgren BR, Rubin N, Murphy SE, Hecht SS, Hatsukami DK, Donny EC.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S38-S45. doi: 10.1093/ntr/ntz133.

15.

The Importance of Estimating Causal Effects for Evaluating a Nicotine Standard for Cigarettes.

Koopmeiners JS, Vock DM, Boatman JA, Carroll D, Colby SM, Donny EC, Hatsukami DK, Luo X, Tidey JW.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S22-S25. doi: 10.1093/ntr/ntz119.

16.

Effects of Very Low Nicotine Content Cigarettes on Smoking Behavior and Biomarkers of Exposure in Menthol and Non-menthol Smokers.

Denlinger-Apte RL, Kotlyar M, Koopmeiners JS, Tidey JW, Luo X, Benowitz NL, Jensen JA, Ikuemonisan JO, Pacek LR, Smith TT, Vandrey R, Donny EC, Hatsukami DK.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S63-S72. doi: 10.1093/ntr/ntz160.

17.

A Randomized Clinical Trial Examining the Effects of Instructions for Electronic Cigarette Use on Smoking-Related Behaviors, and Biomarkers of Exposure.

Hatsukami D, Meier E, Lindgren BR, Anderson A, Reisinger S, Norton K, Strayer L, Jensen J, Dick L, Murphy S, Carmella S, Tang MK, Chen M, Hecht SS, O'Connor RJ, Shields PG.

Nicotine Tob Res. 2019 Dec 12. pii: ntz233. doi: 10.1093/ntr/ntz233. [Epub ahead of print]

PMID:
31828315
18.

Effects of 2-Phenethyl Isothiocyanate on Metabolism of 1,3-Butadiene in Smokers.

Boldry EJ, Yuan JM, Carmella SG, Wang R, Tessier K, Hatsukami DK, Hecht SS, Tretyakova NY.

Cancer Prev Res (Phila). 2020 Jan;13(1):91-100. doi: 10.1158/1940-6207.CAPR-19-0296. Epub 2019 Nov 26.

PMID:
31771940
19.

Very low nicotine content cigarettes disrupt the feedback loop of affective states and smoking behavior.

Robinson JD, Kypriotakis G, al'Absi M, Denlinger-Apte RL, Drobes DJ, Leischow S, McClernon FJ, Pacek LR, Severson H, Smith TT, Donny EC, Luo X, Jensen JA, Strayer LG, Cinciripini PM, Hatsukami DK.

Nicotine Tob Res. 2019 Nov 8. pii: ntz209. doi: 10.1093/ntr/ntz209. [Epub ahead of print]

PMID:
31701153
20.

Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events.

Frobert O, Reitan C, Hatsukami DK, Pernow J, Omerovic E, Andell P.

Open Heart. 2019 Oct 15;6(2):e001109. doi: 10.1136/openhrt-2019-001109. eCollection 2019.

21.

Smoking topography characteristics during a six-week trial of very low nicotine content cigarettes in smokers with serious mental illness.

Denlinger-Apte RL, Donny EC, Lindgren BR, Rubin N, Goodwin C, DeAtley T, Colby SM, Cioe PA, Hatsukami DK, Tidey JW.

Nicotine Tob Res. 2019 Oct 19. pii: ntz198. doi: 10.1093/ntr/ntz198. [Epub ahead of print]

PMID:
31628475
22.

Cigarette Smokers vs. Co-users of Cannabis and Cigarettes: Exposure to Toxicants.

Meier E, Vandrey R, Rubin N, Pacek LR, Jensen JA, Donny EC, Hecht SS, Carmella SG, Murphy SE, Luo X, Stepanov I, Ikuemonisan J, Severson H, al'Absi M, Hatsukami DK.

Nicotine Tob Res. 2019 Oct 16. pii: ntz199. doi: 10.1093/ntr/ntz199. [Epub ahead of print]

PMID:
31616939
23.

Development and Piloting Testing of An Experimental Tobacco and Nicotine Product Marketplace.

Carroll DM, Strayer L, Nardone N, Pacek LR, Kozink RV, Tessier K, McClernon J, Benowitz N, Bickel WK, Hatsukami D.

Nicotine Tob Res. 2019 Oct 11. pii: ntz195. doi: 10.1093/ntr/ntz195. [Epub ahead of print]

PMID:
31603515
24.

Randomized Trial of Low-Nicotine Cigarettes and Transdermal Nicotine.

Smith TT, Koopmeiners JS, Tessier KM, Davis EM, Conklin CA, Denlinger-Apte RL, Lane T, Murphy SE, Tidey JW, Hatsukami DK, Donny EC.

Am J Prev Med. 2019 Oct;57(4):515-524. doi: 10.1016/j.amepre.2019.05.010.

PMID:
31542129
25.

Differences in exposure to toxic and/or carcinogenic volatile organic compounds between Black and White cigarette smokers.

St Helen G, Benowitz NL, Ko J, Jacob P, Gregorich SE, Pérez-Stable EJ, Murphy SE, Hecht SS, Hatsukami DK, Donny EC.

J Expo Sci Environ Epidemiol. 2019 Aug 12. doi: 10.1038/s41370-019-0159-9. [Epub ahead of print]

PMID:
31406274
26.

A Randomized Clinical Trial of Snus Examining the Effect of Complete Versus Partial Cigarette Substitution on Smoking-Related Behaviors, and Biomarkers of Exposure.

Meier E, Lindgren BR, Anderson A, Reisinger SA, Norton KJ, Jensen J, Strayer L, Dick L, Tang MK, Chen M, Carmella SG, Hecht SS, Murphy SE, Yang J, Stepanov I, O'Connor RJ, Shields PG, Hatsukami DK.

Nicotine Tob Res. 2019 Apr 11. pii: ntz055. doi: 10.1093/ntr/ntz055. [Epub ahead of print]

PMID:
31321423
27.

Contemporary Associations of Exclusive Cigarette, Cigar, Pipe, and Smokeless Tobacco Use With Overall and Cause-Specific Mortality in the United States.

Inoue-Choi M, Shiels MS, McNeel TS, Graubard BI, Hatsukami D, Freedman ND.

JNCI Cancer Spectr. 2019 Sep;3(3):pkz036. doi: 10.1093/jncics/pkz036. Epub 2019 May 17. Erratum in: JNCI Cancer Spectr. 2019 Dec 23;4(1):pkz105.

PMID:
31321380
28.

Effects of cessation of cigarette smoking on eicosanoid biomarkers of inflammation and oxidative damage.

McElroy JP, Carmella SG, Heskin AK, Tang MK, Murphy SE, Reisinger SA, Jensen JA, Hatsukami DK, Hecht SS, Shields PG.

PLoS One. 2019 Jun 28;14(6):e0218386. doi: 10.1371/journal.pone.0218386. eCollection 2019.

29.

Betel Nut (areca) and Smokeless Tobacco Use in Myanmar.

Papke RL, Bhattacharyya I, Hatsukami DK, Moe I, Glatman S.

Subst Use Misuse. 2019 Jun 20:1-10. doi: 10.1080/10826084.2019.1624774. [Epub ahead of print] Erratum in: Subst Use Misuse. 2019;54(14):2425.

PMID:
31220988
30.

Strategies to Reduce Illicit Trade of Regular Nicotine Tobacco Products After Introduction of a Low-Nicotine Tobacco Product Standard.

Ribisl KM, Hatsukami DK, Huang J, Williams RS, Donny EC.

Am J Public Health. 2019 Jul;109(7):1007-1014. doi: 10.2105/AJPH.2019.305067.

PMID:
31166743
31.

Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects.

Hatsukami DK, Luo X, Heskin AK, Tang MK, Carmella SG, Jensen J, Robinson JD, Vandrey R, Drobes DJ, Strasser AA, al'Absi M, Leischow S, Cinciripini PM, Koopmeiners J, Ikuemonisan J, Benowitz NL, Donny EC, Hecht SS.

Addiction. 2019 Oct;114(10):1824-1833. doi: 10.1111/add.14695. Epub 2019 Jul 8.

PMID:
31140663
32.

Tobacco-Related Alterations in Airway Gene Expression are Rapidly Reversed Within Weeks Following Smoking-Cessation.

Hijazi K, Malyszko B, Steiling K, Xiao X, Liu G, Alekseyev YO, Dumas YM, Hertsgaard L, Jensen J, Hatsukami D, Brooks DR, O'Connor G, Beane J, Lenburg ME, Spira A.

Sci Rep. 2019 May 6;9(1):6978. doi: 10.1038/s41598-019-43295-3.

33.

Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.

Carmella SG, Heskin AK, Tang MK, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami DK, Hecht SS.

PLoS One. 2019 Apr 25;14(4):e0215853. doi: 10.1371/journal.pone.0215853. eCollection 2019.

34.

Smokeless tobacco control in 180 countries across the globe: call to action for full implementation of WHO FCTC measures.

Mehrotra R, Yadav A, Sinha DN, Parascandola M, John RM, Ayo-Yusuf O, Nargis N, Hatsukami DK, Warnakulasuriya S, Straif K, Siddiqi K, Gupta PC.

Lancet Oncol. 2019 Apr;20(4):e208-e217. doi: 10.1016/S1470-2045(19)30084-1. Review.

PMID:
30942182
35.

"Cold turkey" or pharmacotherapy: Examination of tobacco cessation methods tried among smokers prior to developing head and neck cancer.

Khariwala SS, Rubin N, Stepanov I, Nollen N, Ahluwalia JS, Nelson HH, Hatsukami DK.

Head Neck. 2019 Jul;41(7):2332-2339. doi: 10.1002/hed.25708. Epub 2019 Feb 15.

PMID:
30770605
36.

Biomarkers of Exposure among U.S. Adult Cigar Smokers: Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Chang CM, Rostron BL, Chang JT, Corey CG, Kimmel HL, Sosnoff CS, Goniewicz ML, Edwards KC, Hatsukami DK, Wang Y, Del Valle-Pinero AY, Yang M, Travers MJ, Arnstein S, Taylor K, Conway K, Ambrose BK, Borek N, Hyland A, Wang L, Blount BC, van Bemmel DM.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):943-953. doi: 10.1158/1055-9965.EPI-18-0539. Epub 2019 Feb 7.

PMID:
30733305
37.

Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes.

Goniewicz ML, Smith DM, Edwards KC, Blount BC, Caldwell KL, Feng J, Wang L, Christensen C, Ambrose B, Borek N, van Bemmel D, Konkel K, Erives G, Stanton CA, Lambert E, Kimmel HL, Hatsukami D, Hecht SS, Niaura RS, Travers M, Lawrence C, Hyland AJ.

JAMA Netw Open. 2018 Dec 7;1(8):e185937. doi: 10.1001/jamanetworkopen.2018.5937.

38.

Longitudinal stability in cigarette smokers of urinary biomarkers of exposure to the toxicants acrylonitrile and acrolein.

Chen M, Carmella SG, Sipe C, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami D, Hecht SS.

PLoS One. 2019 Jan 4;14(1):e0210104. doi: 10.1371/journal.pone.0210104. eCollection 2019.

39.

Beliefs about E-cigarettes: A Focus Group Study with College Students.

Katz SJ, Erkinnen M, Lindgren B, Hatsukami D.

Am J Health Behav. 2019 Jan 1;43(1):76-87. doi: 10.5993/AJHB.43.1.7.

40.

Urinary concentrations of monohydroxylated polycyclic aromatic hydrocarbons in adults from the U.S. Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Wang Y, Wong LY, Meng L, Pittman EN, Trinidad DA, Hubbard KL, Etheredge A, Del Valle-Pinero AY, Zamoiski R, van Bemmel DM, Borek N, Patel V, Kimmel HL, Conway KP, Lawrence C, Edwards KC, Hyland A, Goniewicz ML, Hatsukami D, Hecht SS, Calafat AM.

Environ Int. 2019 Feb;123:201-208. doi: 10.1016/j.envint.2018.11.068. Epub 2018 Dec 6.

41.

Biomarker feedback intervention for smoking cessation among Alaska Native pregnant women: Randomized pilot study.

Patten CA, Koller KR, Flanagan CA, Hiratsuka VY, Hughes CA, Wolfe AW, Decker PA, Fruth K, Brockman TA, Korpela M, Gamez D, Bronars C, Murphy NJ, Hatsukami D, Benowitz NL, Thomas TK.

Patient Educ Couns. 2019 Mar;102(3):528-535. doi: 10.1016/j.pec.2018.10.009. Epub 2018 Oct 12.

42.

Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes.

Denlinger-Apte RL, Tidey JW, Koopmeiners JS, Hatsukami DK, Smith TT, Pacek LR, McClernon FJ, Donny EC.

Tob Control. 2019 May;28(3):352-355. doi: 10.1136/tobaccocontrol-2018-054622. Epub 2018 Nov 1.

PMID:
30385649
43.

Assessing the Impact of Conflicting Health Warning Information on Intentions to Use E-Cigarettes -An Application of the Heuristic-Systematic Model.

Katz SJ, Erkkinen M, Lindgren B, Hatsukami D.

J Health Commun. 2018;23(10-11):874-885. doi: 10.1080/10810730.2018.1533052. Epub 2018 Oct 25.

44.

Urine 4-(methylnitrosamino)-1-(3) pyridyl-1-butanol and cotinine in Alaska native postpartum women and neonates comparing smokers and smokeless tobacco users.

Benowitz NL, Flanagan CA, Thomas TK, Koller KR, Wolfe AW, Renner CC, Hughes C, Decker PA, Hatsukami DK, Murphy NJ, Patten C.

Int J Circumpolar Health. 2018 Dec;77(1):1528125. doi: 10.1080/22423982.2018.1528125.

45.

The Debate About Nicotine Addiction and the Role of Medicinal Products: Commentary on Zeller.

Hatsukami DK, Donny EC.

Nicotine Tob Res. 2019 Feb 18;21(3):338-339. doi: 10.1093/ntr/nty195. No abstract available.

46.

Reducing Nicotine in Cigarettes to Minimally Addictive Levels: A New Frontier for Tobacco Control.

Hatsukami DK.

JAMA Psychiatry. 2018 Oct 1;75(10):987-988. doi: 10.1001/jamapsychiatry.2018.1829. No abstract available.

PMID:
30285225
47.

E-cigarettes Warning Labels and Modified Risk Statements: Tests of Messages to Reduce Recreational Use.

Katz SJ, Lindgren B, Hatsukami D.

Tob Regul Sci. 2017 Oct;3(4):445-458. doi: 10.18001/TRS.3.4.6.

48.

Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial.

Hatsukami DK, Luo X, Jensen JA, al'Absi M, Allen SS, Carmella SG, Chen M, Cinciripini PM, Denlinger-Apte R, Drobes DJ, Koopmeiners JS, Lane T, Le CT, Leischow S, Luo K, McClernon FJ, Murphy SE, Paiano V, Robinson JD, Severson H, Sipe C, Strasser AA, Strayer LG, Tang MK, Vandrey R, Hecht SS, Benowitz NL, Donny EC.

JAMA. 2018 Sep 4;320(9):880-891. doi: 10.1001/jama.2018.11473.

49.

Tobacco biomarkers and genetic/epigenetic analysis to investigate ethnic/racial differences in lung cancer risk among smokers.

Murphy SE, Park SL, Balbo S, Haiman CA, Hatsukami DK, Patel Y, Peterson LA, Stepanov I, Stram DO, Tretyakova N, Hecht SS, Le Marchand L.

NPJ Precis Oncol. 2018 Aug 22;2:17. doi: 10.1038/s41698-018-0057-y. eCollection 2018. Review.

50.

Presence of the Carcinogen N'-Nitrosonornicotine in Saliva of E-cigarette Users.

Bustamante G, Ma B, Yakovlev G, Yershova K, Le C, Jensen J, Hatsukami DK, Stepanov I.

Chem Res Toxicol. 2018 Aug 20;31(8):731-738. doi: 10.1021/acs.chemrestox.8b00089. Epub 2018 Jul 30.

PMID:
30019582

Supplemental Content

Loading ...
Support Center